You are here

Article Text

Article menu
Download PDFPDF
Letter
Abatacept in relapsing polychondritis

https://doi.org/10.1136/annrheumdis-2013-203319

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors SLP, DR: conception and design, acquisition of data or analysis and interpretation of data. SLP: drafting the article or revising it critically for important intellectual content. SLP, DR: final approval of the version published.

    • Funding This work was supported in part by a grant from Bristol-Meyers Squibb to the Benaroya Research Institute.

    • Competing interests This study was supported in part by a grant from Bristol-Meyers Squibb, the manufacturer of abatacept, to the Benaroya Research Institute.

    • Ethics approval Benaroya Research Institute.

    • ClinicalTrials.gov identifier NCT01272856

    • Provenance and peer review Not commissioned; internally peer reviewed.